Patient-Derived Ovarian Cancer Organoids Mimic Clinical Response and Exhibit Heterogeneous Inter- and Intrapatient Drug Responses

de Witte, Chris Jenske, Espejo Valle-Inclan, Jose, Hami, Nizar, Lõhmussaar, Kadi, Kopper, Oded, Vreuls, Celien Philomena Henrieke, Jonges, Geertruida Nellie, van Diest, Paul +8 more·2020·Cell Reports

DOI 10.1016/j.celrep.2020.107762

Cited by (307)

Items 101–200 of 307

Patient-derived organoids for precision oncology: a platform to facilitate clinical decision making
Swati Chitrangi, Pooja Vaity, Aishwarya Jamdar, Shweta Bhatt · 2023 · BMC Cancer
Future theranostic strategies: emerging ovarian cancer biomarkers to bridge the gap between diagnosis and treatment
Weranga Rajapaksha, Riya Khetan, Ian R. Johnson, Anton Blencowe, Sanjay Garg, Hugo Albrecht, Todd A. Gillam · 2024 · Frontiers in Drug Delivery
Patient-derived glioblastoma organoids reflect tumor heterogeneity and treatment sensitivity
Maikel Verduin, Linde Hoosemans, Maxime Vanmechelen, Mike van Heumen, Jolanda A. F. Piepers, Galuh Astuti, Linda P.C.M. Ackermans, Olaf E. M. G. Schijns, Kim Rosalie Kampen, Vivianne C. G. Tjan‐Heijnen et al. · 2023 · Neuro-Oncology Advances
New developments and applications of human organoids
Amanda Andersson-Rolf, Hans C. Clevers · 2026 · Nature Reviews Molecular Cell Biology
Multimodal predictors for precision immunotherapy
Lisanne M. Roelofsen, Paulien Kaptein, Daniela S. Thommen · 2022 · Immuno-Oncology Technology
Engineered nano-aluminum adjuvant for cancer immunotherapy: Progress, challenges and opportunities towards preclinical/clinical application
Chong Gao, Jianping Jiang, Jing Zhao, Zhi Ping Xu, Lingxiao Louis Zhang · 2024 · Coordination Chemistry Reviews
Exploring the Potential of Drug Response Assays for Precision Medicine in Ovarian Cancer
Tanya Singh, Adam S. Neal, Neda A. Moatamed, Sanaz Memarzadeh · 2020 · International Journal of Molecular Sciences
In vitro drug testing using patient-derived ovarian cancer organoids
Lin‐Yu Chen, Yu-Ting Chou, Phui‐Ly Liew, Ling-Hui Chu, Kuo‐Chang Wen, Shiou‐Fu Lin, Yu‐Chun Weng, Hui-Chen Wang, Po‐Hsuan Su, Hung‐Cheng Lai · 2024 · Journal of Ovarian Research
Patient-Derived Organoids: The Beginning of a New Era in Ovarian Cancer Disease Modeling and Drug Sensitivity Testing
Iason Psilopatis, Alexandros G. Sykaras, Georgios Mandrakis, Kleio Vrettou, Stamatios E Theocharis · 2022 · Biomedicines
Patient‐derived organoid culture in epithelial ovarian cancers—Techniques, applications, and future perspectives
Wai Sun Chan, Xue-Tang Mo, Philip P.C. Ip, Ka Yu Tse · 2023 · Cancer Medicine
Single-cell transcriptomics identifies a WNT7A-FZD5 signaling axis that maintains fallopian tube stem cells in patient-derived organoids
Abdulkhaliq Alsaadi, Mara Artibani, Zhiyuan Hu, Nina C Wietek, Matteo Morotti, Laura Santana González, Móiad Alazzam, Jason Jiang, Beena Abdul, Hooman Soleymani majd et al. · 2023 · Cell Reports
Preclinical tumor organoid models in personalized cancer therapy: Not everyone fits the mold
Lifeng Hu, Xue Yang, Huanrong Lan, Xingliang Fang, Xiaoyi Chen, Ketao Jin · 2021 · Experimental Cell Research
Modeling the Tumor Microenvironment of Ovarian Cancer: The Application of Self-Assembling Biomaterials
Ana Karen Mendoza-Martinez, Daniela Loessner, Álvaro Mata, Helena S. Azevedo · 2021 · Cancers
Organoids in ovarian cancer: a platform for disease modeling, precision medicine, and drug assessment
Haiyao Hu, Chongen Sun, Jingyao Chen, Zhengyu Li · 2024 · Journal of Cancer Research and Clinical Oncology
Human Endometrial Organoids: Recent Research Progress and Potential Applications
Liqun Lou, Shuangbo Kong, Yunyan Sun, Zhenbo Zhang, Haibin Wang · 2022 · Frontiers in Cell and Developmental Biology
Human Plasma-Derived 3D Cultures Model Breast Cancer Treatment Responses and Predict Clinically Effective Drug Treatment Concentrations
Kristin Calar, Simona Plesselova, Somshuvra Bhattacharya, Megan M. Jorgensen, Pilar de la Puente · 2020 · Cancers
Organoid Models for Cancer Research—From Bed to Bench Side and Back
Carolin Kastner, Anne Hendricks, Hanna Deinlein, Mohammed K. Hankir, Christoph‐Thomas Germer, Stefanie Schmidt, Armin Wiegering · 2021 · Cancers
Nanopore-based consensus sequencing enables accurate multimodal tumor cell-free DNA profiling
Li‐Ting Chen, Myrthe Jager, Dàmi Rebergen, Geertruid Johanna Brink, Tom van den Ende, Willem Vanderlinden, Pauline J. Kolbeck, Marc Pagès-Gallego, Ymke van der Pol, Nicolle J.M. Besselink et al. · 2025 · Genome Research
TROP2 as Patient-Tailoring but Not Prognostic Biomarker for Breast Cancer
Xiaoyue Liu, Tianhao Zhou, Yongmei Wang, Min Pei, Guifeng Wang, Wendi Chu, Qi Wang, Shaoqian Du, Hongxia Wang, Chunhe Wang · 2022 · OncoTargets and Therapy
Akt-Activated Endothelium Increases Cancer Cell Proliferation and Resistance to Treatment in Ovarian Cancer Cell Organoids
Jessica Hoarau-Véchot, Morgane Blot-Dupin, Léa Pauly, Cyril Touboul, Shahin Rafii, Arash Rafii, Jennifer Pasquier · 2022 · International Journal of Molecular Sciences
Advances in Tumor Organoids for the Evaluation of Drugs: A Bibliographic Review
Maritza Londoño-Berrío, Cristina Isabel Castro, Ana Isabel Cañas, Isabel Ortiz, Marlon Osorio · 2022 · Pharmaceutics
Insights into high-grade serous carcinoma pathobiology using three-dimensional culture model systems
Emily J. Tomas, Trevor G. Shepherd · 2023 · Journal of Ovarian Research
Phenotyping Tumor Heterogeneity through Proteogenomics: Study Models and Challenges
Diletta Piana, Federica Iavarone, Elisa De Paolis, Gennaro Daniele, Federico Parisella, Angelo Minucci, Viviana Greco, Andrea Urbani · 2024 · International Journal of Molecular Sciences
Liquid biopsy for ovarian cancer using circulating tumor cells: Recent advances on the path to precision medicine
Jiani Yang, Shanshan Cheng, Nan Zhang, Yue Jin, Yu Wang · 2021 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Evolution of precision oncology‐guided treatment paradigms
Ramanuj DasGupta, Aixin Yap, Elena Yaqing Yong, Shumei Chia · 2022 · WIREs Mechanisms of Disease
Organoids in drug development: from predictive models to regulatory integration
Xuyang Song, Xinrong Chen, Qing Chen, Hao Wang, Tao Zhang, Michael Z. Liao, Chunhong Liu, Hongtao Yu, Yanning Hao, Guodong Gu et al. · 2026 · Drug Discovery Today
Patient-derived organoids as a model for tumor research
Jia Wang, Xiaoying Feng, Zhichao Li, Yongsong Chen, Weiren Huang · 2022 · Progress in molecular biology and translational science
Tumor Organoids as a Research Tool: How to Exploit Them
Tijmen H. Booij, Chiara M. Cattaneo, Christian Hirt · 2022 · Cells
Patient-Derived Xenografts and Organoids Recapitulate Castration-Resistant Prostate Cancer with Sustained Androgen Receptor Signaling
Annelies Van Hemelryk, Ingrid Tomljanović, Corrina M. A. de Ridder, Debra C. Stuurman, Wilma J. Teubel, Sigrun Erkens‐Schulze, Esther I. Verhoef, Sebastiaan Remmers, Amrish J. Mahes, Geert J.L.H. van Leenders et al. · 2022 · Cells
A 3D multi-cellular tissue model of the human omentum to study the formation of ovarian cancer metastasis
Manuela Estermann, Ricardo Coelho, Francis Jacob, Yen‐Lin Huang, Ching-Yeu Liang, Ana Bela Faia-Torres, Dedy Septiadi, Barbara Drašler, Bedia Begüm Karakoçak, Irini Magdelina Dijkhoff et al. · 2023 · Biomaterials
Patient-Derived Organoids on a Microarray for Drug Resistance Study in Breast Cancer
Tianyuan Fang, Xinlun Xie, Wei Jie Lu, Zichen Hong, Wenbo Peng, Jun Zhou, Min Wang, Bo Yao · 2024 · Analytical Chemistry
Long-term patient-derived ovarian cancer organoids closely recapitulate tumor of origin and clinical response
Lucie Thorel, Énora Dolivet, Pierre‐Marie Morice, Romane Florent, Jordane Divoux, Marion Perréard, Lucie Lecouflet, Guillaume Desmartin, Chloé Marde Alagama, Florence Giffard et al. · 2025 · Journal of Experimental & Clinical Cancer Research
Novel Ex Vivo Models of Epithelial Ovarian Cancer: The Future of Biomarker and Therapeutic Research
James A. Clark, Christina Fotopoulou, Paula Cunnea, Jonathan Krell · 2022 · Frontiers in Oncology
The organoid as reliable cancer modeling in personalized medicine, does applicable in precision medicine of head and neck squamous cell carcinoma?
Alieh Farshbaf, Malihe Lotfi, Reza Zare, Nooshin Mohtasham · 2022 · The Pharmacogenomics Journal
Ovarian Cancer Patient-Derived Organoid Models for Pre-Clinical Drug Testing
Bisiayo Fashemi, Lillian van Biljon, Jeimmy Rodriguez, Olivia Graham, Mary Mullen, Dineo Khabele · 2023 · Journal of Visualized Experiments
A synthetic lethal dependency on casein kinase 2 in response to replication-perturbing therapeutics in RB1-deficient cancer cells
Daria R. Bulanova, Yevhen A. Akimov, Wojciech Senkowski, Jaana Oikkonen, Laura Gall-Mas, Sanna Timonen, Manar Elmadani, Johanna Hynninen, Sampsa Hautaniemi, Tero A. Aittokallio et al. · 2024 · Science Advances
The OVAREX study: Establishment of ex vivo ovarian cancer models to validate innovative therapies and to identify predictive biomarkers
Lucie Thorel, Jordane Divoux, Justine Lequesne, Guillaume Babin, Pierre‐Marie Morice, Romane Florent, Guillaume Desmartin, Lucie Lecouflet, Chloé Marde Alagama, Alexandra Leconte et al. · 2024 · BMC Cancer
Integrative analysis of patient-derived tumoroids and ex vivo organoid modelling of ARID1A loss in bladder cancer reveals therapeutic molecular targets
Mathijs Scholtes, Maryam Akbarzadeh, Αλέξανδρος Γαλάρας, José Alberto Nakauma‐González, Ameneh Bazrafshan, Vandana Solanki, Bram Torenvliet, Leila Beikmohammadi, Valeria Lozovanu, Shahla Romal et al. · 2025 · Cancer Letters
Constructing a co-culture model of cancer-associated fibroblasts and ovarian cancer organoids and studying mechanisms of drug resistance
Xiaoxing Ma, Fengqin Xue, Zhihua Pei, Ye Zhao · 2025 · Experimental Cell Research
Advances and Challenges in Drug Screening for Cancer Therapy: A Comprehensive Review
Shohei Motohashi, Eriko Katsuta, Daisuke Ban · 2025 · Bioengineering
A Scalable 3D High-Content Imaging Protocol for Measuring a Drug Induced DNA Damage Response Using Immunofluorescent Subnuclear γH2AX Spots in Patient Derived Ovarian Cancer Organoids
Hakan Keles, Christopher Schofield, Helena Rannikmäe, Erin Elizabeth Edwards, Lisa Mohamet · 2022 · ACS Pharmacology & Translational Science
Exploiting a living biobank to delineate mechanisms underlying disease-specific chromosome instability
Louisa Nelson, Bethany M. Barnes, Anthony Tighe, Samantha Littler, Camilla Coulson‐Gilmer, Anya Golder, Sudha N. Desai, Robert David Morgan, Joanne C. McGrail, Stephen S. Taylor · 2023 · Chromosome Research
Establishing mesothelioma patient-derived organoid models from malignant pleural effusions
Ashleigh Jean Hocking, Lauren A. Mortimer, Alexandra L. Farrall, Prudence Anne Russell, Sonja Klebe · 2024 · Lung Cancer
The use of organoids in creating immune microenvironments and treating gynecological tumors
Ling-Feng Zhou, Hui-Yan Liao, Yang Han, Yang Zhao · 2024 · Journal of Translational Medicine
Tumor organoids in cancer medicine: from model systems to natural compound screening
Rong Cong, Can Lu, Xinying Li, Zhijie Xu, Yaqin Wang, Shusen Sun · 2025 · Pharmaceutical Biology
Application and research progress of organoids in cholangiocarcinoma and gallbladder carcinoma.
Yun-peng Huang, Kai Liu, Yongxiang Wang, Yang Yang, Li Xiong, Zijian Zhang, Yu Wen · 2021 · PubMed Central
Optimal, Large-Scale Propagation of Mouse Mammary Tumor Organoids
Emma D. Wrenn, Breanna M. Moore, Erin Greenwood, Margaux McBirney, Kevin J. Cheung · 2020 · Journal of Mammary Gland Biology and Neoplasia
Ex vivo chemosensitivity assay using primary ovarian cancer organoids for predicting clinical response and screening effective drugs
Yu Ito, Jumpei Kondo, Masamune Masuda, Shinya Matsuzaki, Kunishige Onuma, Mizuki Kanda, Yuko Watanabe, Hitomi Sakaguchi, Kiyoshi Yoshino, Yutaka Ueda et al. · 2022 · Human Cell
Patient-Derived In Vitro Models of Ovarian Cancer: Powerful Tools to Explore the Biology of the Disease and Develop Personalized Treatments
Chiara Battistini, Ugo Cavallaro · 2023 · Cancers
Advances and challenges in the origin and evolution of ovarian cancer organoids
Mengpei Zhang, Rutie Yin, Kemin Li · 2024 · Frontiers in Oncology
Patient-derived organoids predict responses to chemotherapy and PARP inhibitors in advanced ovarian cancer
Haixia Wang, Ling Wang, Xueping Zhu, Misi He, Lin Zhong, Yuyu Lv, Qiaoling Li, Qinyue Jiang, Cong Zhang, Xinghe Liu et al. · 2026 · Journal of Translational Medicine
Translational Pharmacokinetic/Pharmacodynamic Modeling and Simulation of Oxaliplatin and Irinotecan in Colorectal Cancer
Jinwei Zhu, Yicui Zhang, Yixin Zhao, Jingwei Zhang, Kun Hao, Hua He · 2023 · Pharmaceutics
A systematic review of patient-derived tumor organoids generation from malignant effusions
Sofie Seghers, Maxim Le Compte, Jeroen M.H. Hendriks, Paul E. Van Schil, Annelies Janssens, Reinier R.L. Wener, Niels Komen, Hans Prenen, Christophe Deben · 2024 · Critical Reviews in Oncology/Hematology
Immunomodulatory Natural Products in Cancer Organoid-Immune Co-Cultures: Bridging the Research Gap for Precision Immunotherapy
Chang‐Eui Hong, Su‐Yun Lyu · 2025 · International Journal of Molecular Sciences
Protocol for drug screening of patient-derived tumor organoids using high-content fluorescent imaging
Brian M. Larsen, Andrea Cancino, Jenna M. Shaxted, Ameen Abdulla Salahudeen · 2022 · STAR Protocols
Functional Precision Oncology: The Next Frontier to Improve Glioblastoma Outcome?
Dena Panovska, Frederik De Smet · 2022 · International Journal of Molecular Sciences
Assessment of source material for human intestinal organoid culture for research and clinical use
Paulo C. M. Urbano, Hamish C. K. Angus, Safina Gadeock, Michael Schultz, Roslyn A. Kemp · 2022 · BMC Research Notes
Organoids derived from metastatic cancers: Present and future
Xuejing Zheng, Xinxin Zhang, Shengji Yu · 2024 · Heliyon
Organoid technologies in antitumor drug screening: past development, present applications, and future prospects
Junfa Yang, Yipin Yang, Pengkai Xu, Yong Yao, Heng Tian, Xinyi Wang, Hui Fang, Shangqing Ge, Yan Yao, Yafen Wang et al. · 2025 · International Journal of Surgery
Organoids: approaches and utility in cancer research
Bing‐Rui Zhou, Zhiwei Feng, Jun Xu, Jun Xie · 2023 · Chinese Medical Journal
Effective Treatment for Recurrent Ovarian Cancer Guided by Drug Sensitivity from Ascites-Derived Organoid: A Case Report
Wanyi Chen, Po-Han Fang, Bin Zheng, Yue Liang, Yiwen Mao, Xuefeng Jiang, Qiong-Lan Tang · 2023 · International Journal of Women s Health
Combining Organoid Models with Next-Generation Sequencing to Reveal Tumor Heterogeneity and Predict Therapeutic Response in Breast Cancer
Yuhong Liu, Yi‐Xiang Gan, NiJiati AiErken, Wei Chen, Shiwei Zhang, Jie Ouyang, Leli Zeng, Di Tang · 2022 · Journal of Oncology
Patient-derived organoids in ovarian cancer: Current research and its clinical relevance
Sanjay Kumar, Manita Raina, Kalpana Tankay, Gaurav Milind Ingle · 2023 · Biochemical Pharmacology
Ovarian Cancer Patient-Derived Organoids Used as a Model for Replicating Genetic Characteristics and Testing Drug Responsiveness: A Preliminary Study
Yu‐Hsun Chang, Kun‐Chi Wu, Kai‐Hung Wang, Dah‐Ching Ding · 2024 · Cell Transplantation
Organoid modeling meets cancers of female reproductive tract
Jiao Li, Mengting Zhou, Jun Hua Xie, Jiani Chen, Mengni Yang, Changjun Ye, Shihu Cheng, Miao Liu, Rui Li, Ruirong Tan · 2024 · Cell Death Discovery
Development and Applications of Organoids in Gynecological Diseases
Jian Yang, Wen Li, Zihan Zhang, Zhonglei Xu, Wenjing Zhu, Jing Wang, Wenyan Wang · 2024 · Stem Cell Reviews and Reports
Combinatorial screening of nanomedicines in patient-derived cancer organoids facilitates efficient cancer therapy
Jie Liang, Dong‐Kun Zhao, Hao-Ming Yin, Tai-Yu Tian, Jian-Kang Kang, Song Shen, Jun Wang · 2025 · Nano Today
Female Reproductive Tract Organoids: Applications from Physiology to Pathology
Xinyu Wang, Diqi Yang, Hui Peng · 2025 · Biomolecules
Ex vivo 3D micro-tumour testing platform for predicting clinical response to platinum-based therapy in patients with high-grade serous ovarian cancer
Esmee Koedoot, Dieudonne J. van der Meer, Anne M. van Altena, L. Ceton, Timothy J. P. Sijsenaar, Marta G. Montero, Fanny Grillet, Jurgen M.J. Piek, Ruud L.M. Bekkers, Maurice J. D. L. van der Vorst et al. · 2025 · npj Precision Oncology
A chronicle review of new techniques that facilitate the understanding and development of optimal individualized therapeutic strategies for chordoma
Chenglong Zhao, Tao Tan, E. Zhang, Ting Wang, Haiyi Gong, Qi Jia, Tielong Liu, Xinghai Yang, Jian Zhao, Zhipeng Wu et al. · 2022 · Frontiers in Oncology
NPEPPS Is a Druggable Driver of Platinum Resistance
Robert T. Jones, Mathijs Scholtes, Andrew E. Goodspeed, Maryam Akbarzadeh, Saswat Mohapatra, Lily Elizabeth Feldman, Hedvig Vékony, Annie Jean, Charlene B. Tilton, Michael V. Orman et al. · 2024 · Cancer Research
Establishment and characterization of multiple patient-derived organoids from a case of advanced endometrial cancer
Yoshiaki Maru, Mami Kohno, Kiyomi Suzuka, Akiko Odaka, Mari Masuda, Akinobu Araki, Makiko Itami, Naotake Tanaka, Yoshitaka Hippo · 2024 · Human Cell
Three Dimensional Models of Endocrine Organs and Target Tissues Regulated by the Endocrine System
Edlira Luca, Kathrin Zitzmann, Stefan Richard Bornstein, Patrick Kugelmeier, Felix Beuschlein, Svenja Nölting, Constanze Hantel · 2023 · Cancers
Enhancing chemotherapy response prediction via matched colorectal tumor-organoid gene expression analysis and network-based biomarker selection
Wei Zhang, Chao Wu, Hanchen Huang, Paulina Bleu, Wini V. Zambare, Janet A. Alvarez, Lily Wang, Philip B. Paty, Paul Bernard Romesser, Jesse Joshua Smith et al. · 2025 · Translational Oncology
Advancing oncology drug development: Innovative approaches to enhance success rates while reducing animal testing
Hans R. Hendriks · 2025 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Human fallopian tube epithelial organoids with TP53 mutation recapitulate features of serous tubal intraepithelial carcinoma (STIC)
Judith Kraiczy, Bo Yu · 2025 · Gynecologic Oncology
Chemoresistance in Ovarian Cancer: The Role of Malignant Ascites
Mariana Nunes, Sara Alexandra Vinhas Ricardo · 2022 · Exon Publications eBooks
Using genetically encoded fluorescent biosensors to interrogate ovarian cancer metabolism
Shree Bose, Haipei Yao, Qiang Huang, Regina S. Whitaker, Christopher D. Kontos, Rebecca A. Previs, Xiling Shen · 2022 · Journal of Ovarian Research
Clinical Relevance of Patient-Derived Organoid of Surgically Resected Lung Cancer as an In Vitro Model for Biomarker and Drug Testing
T. Koga, Junichi Soh, Akira Hamada, Yuki Miyano, Toshio Fujino, Keiko Obata, Shuta Ohara, Masaya Nishino, Masato Chiba, Masaki Shimoji et al. · 2023 · JTO Clinical and Research Reports
Tumor Organoid as a Drug Screening Platform for Cancer Research
Reyhaneh Mahbubi Arani, Niloufar Yousefi, Amir Ali Hamidieh, Fatemeh Gholizadeh, Mahsa Mollapour Sisakht · 2023 · Current Stem Cell Research & Therapy
Multiplexed Live-Cell Imaging for Drug Responses in Patient-Derived Organoid Models of Cancer
Kaitriana E. Colling, Emily L. Symons, Lorenzo Buroni, Hiruni K. Sumanasiri, Jessica Andrew-Udoh, Emily Witt, Haley A. Losh, Abigail M. Morrison, Kimberly Kay Leslie, Christopher Dunnill et al. · 2024 · Journal of Visualized Experiments
Zengmian Yiliu formula suppresses cell cycle in immune-rich ovarian cancer patient-derived organoids
Qi Cao, Chunhui Cai, Chen Wang, Lanyang Li, Jiping Liu, Jiän Zhang, Mingjie Rong, Jiaqi Ren, Yanyan Han, Jie Zhang et al. · 2025 · Phytomedicine
Endocrine cancer organoids in basic and translational medical research
Dong Chen, Zhulan Chen, Huihui Yang, Lei Zhang, Chenchen Hu, Zhuo Yang, Peng Li, Xi Su, Xiaoling Liu, Wei Wei et al. · 2025 · Science China Life Sciences
Organoid models established from primary tumors and patient-derived xenograft tumors reflect platinum sensitivity of ovarian cancer patients
Parisa Nikeghbal, Dorsa Zamanian, Danielle Burke, Mara P. Steinkamp · 2025 · BMC Cancer
Biomaterial-Based Delivery Systems for Chemotherapeutics
Dalapathi B Gugulothu, Dimple Dhawan, Alisha Sachdeva, Deepali, Meenakshi Kanwar Chauhan · 2023 · Biological and medical physics, biomedical engineering
Targeting RAS-ERK pathway alterations with MEK inhibitors to improve chemosensitivity in high grade serous ovarian cancers
Nancy Nguyen, Alan G. Raetz, Dennis J. Montoya, Vincent Schilling, Caili Tong, Rebecca A. Brooks, Gary Scott Leiserowitz, JEREMY R. CHIEN · 2023 · Gynecologic Oncology
Short-term cultured tumor fragments to study immunotherapy combinations based on CD137 (4-1BB) agonism
Iñaki Eguren‐Santamaría, Inmaculada Rodríguez, Claudia Herrero, Eva Fernández de Piérola, Arantza Azpilikueta, Sandra Sánchez‐Gregorio, Elixabet Bolaños, Gabriel Gomis, Paula Molero-Glez, Enrique Chacón et al. · 2024 · OncoImmunology
Exploiting Cancer Dormancy Signaling Mechanisms in Epithelial Ovarian Cancer Through Spheroid and Organoid Analysis
Emily J. Tomas, Yudith Ramos Valdés, Jennifer Davis, Bart Kolendowski, Adrian V. Buensuceso, Gabriel E. DiMattia, Trevor G. Shepherd · 2025 · Cells
Differences in chemotherapeutic drug sensitivity before and after patient-derived tumor organoid construction
Fang Shao, Xin Hua Huang, Zhihong Ma, Liqin Li, Chunjian Qi · 2025 · Toxicology and Applied Pharmacology
Single-cell technology: the key to an improved understanding of the human endometrium in health and disease
Javier González-Fernández, Sofía Zaragozano, Ana Monteagudo, Carlos Simón, Felipe Vilella · 2025 · American Journal of Obstetrics and Gynecology
Perfusion-based ex vivo culture of frozen ovarian cancer tissues with preserved tumor microenvironment
Monica De Luise, Ivana Kurelac, Sara Coluccelli, Antonio De Leo, Ewelina Magdalena Bartoszek, Maria Iorio, Marco Grillini, Camelia Alexandra Coadǎ, Dario de Biase, Lorena Marchio et al. · 2025 · npj Precision Oncology
Ex vivo drug screening on patient-derived tumor material to advance functional precision in oncology: an overview on current approaches and unresolved challenges
Zoltán Spiró, El-Heliebi Amin, Maximilian J. Mair, Thomas R Pieber, Barbara Prietl, Sabine Spiegl‐Kreinecker, Stefanie Stanzer, Adelheid Wöhrer, Matthias Preusser, Anna Sophie Berghoff · 2025 · Cancer Treatment Reviews
Intra- and Interpatient Drug Response Heterogeneity Exist in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Nongynecologic Cancers
Shannon N. Radomski, Matthew Dunworth, Junior J. West, Jonathan B. Greer, Fabian Mc. Johnston, Andrew J. Ewald · 2024 · Annals of Surgical Oncology
Bioengineering approaches to improve gynecological cancer outcomes
Ali Abbaspour, Andrea L. Casillas, Stephanie M. McGregor, Pamela K. Kreeger · 2022 · Current Opinion in Biomedical Engineering
Changes in Stem Cell Regulation and Epithelial Organisation during Carcinogenesis and Disease Progression in Gynaecological Malignancies
Paula Cunnea, Christina Fotopoulou, Jennifer Ploski, Fabian Trillsch, Sven� Mahner, Mirjana Kessler · 2021 · Cancers
Prospects and challenges of ovarian cancer organoids in chemotherapy research (Review)
Weijia Zhang, Yuqing Ding, Hui He, Keming Chen, Qingsong Zeng, Xiaoming Cao, Ying Xiang, Hai Zeng · 2025 · Oncology Letters
Large scale quantification of natural killer cell-induced apoptosis in patient-derived organoids reveals intratumoral response heterogeneity
Marisa Mercadante, Armin Scheben, Jacob Estrada, Jan Savas-Carstens, William Sullivan, Nicholas Housel, Maria L. Sapar, Tatiana Volpari, Jax Hebner, Tomasz Rusielewicz et al. · 2025 · npj Precision Oncology
Harnessing human tumor organoids for cancer modeling and precision therapy
Tonghai Zhou, Qianyi Wang, Zhang Mei-li, Yue Huang · 2026 · Protein & Cell
Combination of Genomic Landsscape and 3D Culture Functional Assays Bridges Sarcoma Phenotype to Target and Immunotherapy
Filomena de Nigris, Concetta Meo, Wulf Palinski · 2023 · Cells
Research progress on the application of organoids in gynecological tumors
Ying Shen, Yu Wang, Siyu Wang, Chan Li, Feng‐Juan Han · 2024 · Frontiers in Pharmacology